Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.
暂无分享,去创建一个
T Nakamura | M. Matsuda | S. Kihara | S. Yamashita | T. Funahashi | Y. Matsuzawa | T. Nakamura | H. Kuriyama | M. Muraguchi | K. Hasegawa | K. Hotta | T. Hanafusa | M. Nishida | N. Ouchi | Y. Ohmoto | M. Takahashi | N. Sakai | Y Okamoto | Y Arita | M Nishida | M Muraguchi | N Ouchi | M Takahashi | S Kihara | S Yamashita | T Funahashi | Y Matsuzawa | K. Hasegawa | N Sakai | H Kuriyama | H. Iwahashi | K Maeda | K Hotta | Y Ohmoto | Y. Arita | Y. Okamoto | K. Maeda | M. Nishida | T. Nakajima | Y. Ohmoto | Tadashi Nakamura | T Hanafusa | T Nakajima | M Matsuda | H Iwahashi | K Hasegawa | Masahiko Takahashi
[1] T Nakamura,et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.
[2] P. Morange,et al. Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease , 1997, Diabetes.
[3] J. Ohannesian,et al. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. , 1996, The Journal of clinical investigation.
[4] Y. Nakano,et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. , 1996, Journal of biochemistry.
[5] P. Vague,et al. Increased Plasminogen Activator Inhibitor Activity in Non Insulin Dependent Diabetic Patients – Relationship with Plasma Insulin , 1989, Thrombosis and Haemostasis.
[6] J. Auwerx,et al. Tissue‐Type Plasminogen Activator Antigen and Plasminogen Activator Inhibitor in Diabetes Mellitus , 1988, Arteriosclerosis.
[7] R. Considine,et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.
[8] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.
[9] B. Spiegelman,et al. Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.
[10] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[11] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[12] S. Yamashita,et al. Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.
[13] P. Zimmet. Kelly West Lecture 1991 Challenges in Diabetes Epidemiology—From West to the Rest , 1992, Diabetes Care.
[14] S. Coppack,et al. Adipose tissue as an endocrine and paracrine organ , 1998, International Journal of Obesity.
[15] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[16] R. Hammer,et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy , 1999, Nature.
[17] B. Spiegelman,et al. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. Grimaldi,et al. Cellular and molecular aspects of adipose tissue development. , 1992, Annual review of nutrition.
[19] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[20] R. Considine,et al. Leptin: The Tale of an Obesity Gene , 1996, Diabetes.
[21] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[22] T Nakamura,et al. An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[23] E. Ravussin,et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.
[24] G. Inoue,et al. Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. , 1999, Diabetes.